DAN NGUYEN: Open Payments
NPI 1821398314 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $106 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $114 |
| Novo Nordisk Inc | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Kerendia, UZEDY, Ozempic, XOLAIR, MOUNJARO, JARDIANCE.
Industry payments across CA — which companies pay providers there.
